Myeloid-derived suppressor cells (MDSC) assessment using an automated sequential chromogenic multiplex assay (Brightplex®)
What's in the poster?
This poster was presented at the Society for Immunotherapy of Cancer (SITC) conference in 2018. This work will provide:
- a background on the biology of myeloid-derived suppressor cells (MDSCs) in the context of non-small cell lung cancer (NSCLC)
- a showcase of the Brightplex® MDSC multiplex IHC panel comprised of CD11b, CD14, CD15, HLA-DR, LOX1, and S100A9
- phenotypic analysis strategies for tissue segmentation and quantifying cell densities of MDSC subtypes